Ezio Bonvini
Senior VP of Research & Chief Scientific OfficerDr. Ezio Bonvini, M.D., has been Chief Scientific Officer and Senior Vice President of Research at MacroGenics, Inc. since September 2016. Dr. Bonvini serves as Acting Head of Clinical Development at MacroGenics, Inc since March 2020 until 2020 and served as Interim Head of Clinical Development and Interim Chief Medical Officer at MacroGenics, Inc. since March 27, 2020 until 2020. Dr. Bonvini served as Vice President of Clinical Research at MacroGenics, Inc. Dr. Bonvini, a hematologist by training, is an expert in immunobiology and joined MacroGenics since June 2003 and served as Vice President of Research since November 2004. He joined MacroGenics, Inc. in June 2003. He has research, regulatory and clinical trial design experience spent at the National Cancer Institute, the National Institutes of Health and more recently at the Food and Drug Administration (FDA) in the Center for Biologics Evaluation and Research (CBER), which is responsible for regulating therapeutic monoclonal antibodies and other proteins. From 1982 to 1984, Dr. Bonvini was a Visiting Fellow at the National Cancer Institute at the National Institutes of Health. Dr. Bonvinis research dealt with the molecular mechanism of signal transduction by immune receptors in leukocyte activation. During his tenure at CBER, he held several leadership positions as Acting Deputy Director of Monoclonal Antibodies, most recently as the Acting Deputy Division Director and Chief of the Laboratory of Immunobiology, where he was responsible for supervising the research program and the review of monoclonal antibody products from IND to BLA stages. While at the FDA, he received several awards for his scientific and regulatory work. Dr. Bonvini received a Diploma in Science from the Scientific Lyceum in Genoa, Italy and his M.D. and Specialty Certification in Clinical Hematology from the University of Genoa, School of Medicine.
Positions
- Company NameMacroGenics, Inc.Stock CodeMGNXPositionSenior VP of Research & Chief Scientific OfficerColleagues
- EBEric Blasius RisserCEO, President & Director
- WKWilliam K. HeidenIndependent Chairman of the Board
- JKJames KarrelsSenior VP & CFO
- ALAraba Lamouse-SmithVice President of Technical Operations
- JSJeffrey Stuart PetersSenior VP, Corporate Secretary, General Counsel & Corporate Compliance Officer
- EMEdward M. HurwitzIndependent Director
- FFFederica F. O'BrienIndependent Director
- MCMeenu Chhabra KarsonIndependent Director
